GlassScriptPhysician profile
Nadir Yehya
NPI 1114103199
$18,356.47
in general payments reported to CMS, 2019-2025
3 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.00 · 2023: $18K · 2024: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,800 · Consulting Fee: $8,461 · Food and Beverage: $62.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,800.47 |
| Consulting Fee | $8,460.75 |
| Food and Beverage | $62.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $9,862.72 | 2023 | |
| Astrazeneca Ab | $8,460.75 | 2023-2024 | |
| Vapotherm INC | $33.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadir Yehya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.